The TME contains chemicals such tumor antigens, IL-2, IL-10, TGF-β, and other soluble molecules that stimulate the T-cell receptor (TCR) and enhance the transformation of naive CD4+ T-cells into iTregs [28]. The gene discussed is IL2; the disease is neoplasm.